Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models
- 1 March 1993
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 119 (3) , 142-149
- https://doi.org/10.1007/bf01229528
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment results of the thioether lipid ilmofosine in patients with malignant tumoursZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activityZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Investigation into the immunological effects of miltefosine, a new anticancer agent under developmentZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin—Darby canine kidney cellsFEBS Letters, 1991
- Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patientsCancer Treatment Reviews, 1990
- Computerized determination of growth kinetic curves and doubling times from cells in microcultureAnalytical Biochemistry, 1990
- Grwoth Inhibition of Mouse MXT Mammary Tumor by the Luteinizing Hormone-Releasing Hormone Antagonist SB-75JNCI Journal of the National Cancer Institute, 1990
- Mammary Tumor Inhibiting Properties of the (S,S)‐Configurated [1,2‐Bis(4‐hydroxyphenyl)ethylenediamine]dichloroplatinum(II) ComplexArchiv der Pharmazie, 1990
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinomaJournal of Medicinal Chemistry, 1988